Susquehanna International Group, LLP Annexon, Inc. Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Annexon, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 266,812 shares of ANNX stock, worth $840,457. This represents 0.0% of its overall portfolio holdings.
Number of Shares
266,812
Previous 199,225
33.92%
Holding current value
$840,457
Previous $384,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding ANNX
# of Institutions
139Shares Held
96.4MCall Options Held
0Put Options Held
63.4K-
Satter Management Co., L.P.7.41MShares$23.3 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$22.1 Million0.66% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$20.7 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$19.8 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.37MShares$16.9 Million0.0% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $150M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...